Tumour-specific antibody neutralization of factors in rat hepatoma-bearer serum which abrogate lymph-node-cell cytotoxicity
- 15 November 1974
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 14 (5) , 589-597
- https://doi.org/10.1002/ijc.2910140505
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Abrogation of cell‐mediated immunity by hyperimmune alloantiserum: Mechanisms and correlation with allograft enhancementInternational Journal of Cancer, 1974
- Regression of polyoma tumor metastasis by combined unblocking and bcg treatment‐correlation with induced alterations in tumor immunity statusInternational Journal of Cancer, 1973
- Inhibition of hepatoma‐immune lymph‐node cell cytotoxicity by tumour‐bearer serum, and solubilized hepatoma antigenInternational Journal of Cancer, 1973
- Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour statusInternational Journal of Cancer, 1973
- Serum Mediated Inhibition of the Immunological Reactions of the Patient to his Own Tumour: A Possible Role for Circulating AntigenBritish Journal of Cancer, 1972
- Blocking of Lymphocyte-mediated Cytotoxicity for Rat Hepatoma Cells by Tumour-specific Antigen-Antibody ComplexesNature New Biology, 1972
- Counteraction of the blocking of cell‐mediated tumor immunity by inoculation of unblocking sera and splenectomy: immunotherapeutic effects on primary polyoma tumors in ratsInternational Journal of Cancer, 1972
- “Unblocking” Serum Activity in vitro in the Polyoma System may Correlate with Antitumour Effects of Antiserum in vivoNature New Biology, 1971
- Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour‐specific antigens associated with aminoazo‐dye‐induced rat hepatomasInternational Journal of Cancer, 1971
- Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata.British Journal of Cancer, 1967